Pfizer Prepares To Seek U.S., EU Approval After Study Shows Vaccine Is Safe For Five To 11-Year-Olds Two doses of the Pfizer shot generated a “strong immune response” in kids aged five to 11 similar to that of vaccinated 16 to 25 year olds, the companies said.